Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Malignant Lymphoma

Free Subscription 04.06.2018 3 Bone Marrow Transplant 5 Br J Haematol 4 Curr Treat Options Oncol 1 Eur J Haematol 1 Haematologica 1 J Am Acad Dermatol 3 J Clin Oncol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Bone Marrow Transplant

1. AVIGDOR A, Shouval R, Jacoby E, Davidson T, et al
   CAR T cells induce a complete response in refractory Burkitt Lymphoma.
   Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0235.
   PubMed     Text format    
   
   
2. FUJI S, Kurosawa S, Inamoto Y, Murata T, et al
   Decision analysis of up-front autologous hematopoietic stem cell transplantation in patients with peripheral T-cell lymphoma.
   Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0223.
   PubMed     Text format    
   
   
3. HUBEL K, Ostermann H, Glass B, Noppeney R, et al
   Plerixafor in non-Hodgkin's lymphoma patients: a German analysis of time, effort and costs.
   Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0228.
   PubMed     Text format     Abstract available
   
   

   
   Br J Haematol

4. KURT H, Medeiros LJ, Khoury JD, Schlette EJ, et al
   Epstein-Barr virus-positive follicular lymphoma.
   Br J Haematol. 2018 May 29. doi: 10.1111/bjh.15419.
   PubMed     Text format    
   
   
5. GISSELBRECHT C, Van Den Neste E
   How I manage patients with relapsed/refractory diffuse large B cell lymphoma.
   Br J Haematol. 2018 May 29. doi: 10.1111/bjh.15412.
   PubMed     Text format     Abstract available
   
   
6. FAMA A, Xiang J, Link BK, Allmer C, et al
   Human Pegivirus infection and lymphoma risk and prognosis: a North American study.
   Br J Haematol. 2018 May 29. doi: 10.1111/bjh.15416.
   PubMed     Text format     Abstract available
   
   
7. KOMMALAPATI A, Tella SH, Go RS, Nowakowski GS, et al
   T cell/histiocyte-rich large B cell lymphoma: incidence, demographic disparities, and long-term outcomes.
   Br J Haematol. 2018 May 30. doi: 10.1111/bjh.15391.
   PubMed     Text format    
   
   
8. VAN WESTRHENEN A, Smidt LCA, Seute T, Nierkens S, et al
   Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review.
   Br J Haematol. 2018 May 29. doi: 10.1111/bjh.15410.
   PubMed     Text format     Abstract available
   
   

   
   Curr Treat Options Oncol

9. PETERS S, Zimmermann S
   Management of Resistance to First-Line Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor Therapy.
   Curr Treat Options Oncol. 2018;19:37.
   PubMed     Text format     Abstract available
   
   
10. BECNEL MR, Nastoupil LJ
    Follicular Lymphoma: Past, Present, and Future.
    Curr Treat Options Oncol. 2018;19:32.
    PubMed     Text format     Abstract available
    
    
11. MAJOR A, Kamdar M
    Management of Non-Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder.
    Curr Treat Options Oncol. 2018;19:33.
    PubMed     Text format     Abstract available
    
    
12. RODGERS TD, Barr PM
    Pitfalls of Combining Novel Agents in Lymphoma.
    Curr Treat Options Oncol. 2018;19:35.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Haematol

13. NOESSLINGER T, Panny M, Simanek R, Moestl M, et al
    High dose Bendamustine-EAM followed by autologous stem cell rescue results in long term remission rates in lymphoma patients, without renal toxicty.
    Eur J Haematol. 2018 May 25. doi: 10.1111/ejh.13102.
    PubMed     Text format     Abstract available
    
    

    
    Haematologica

14. ESKELUND CW, Albertsson-Lindblad A, Kolstad A, Laurell A, et al
    Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma.
    Haematologica. 2018 May 24. pii: haematol.2018.194399.
    PubMed     Text format    
    
    

    
    J Am Acad Dermatol

15. YUAN Z, Grass GD, Robinson TJ, Kim S, et al
    Management of primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma: A retrospective study.
    J Am Acad Dermatol. 2018 May 29. pii: S0190-9622(18)30829.
    PubMed     Text format    
    
    

    
    J Clin Oncol

16. FRIEDBERG JW
    Progress in Advanced-Stage Follicular Lymphoma.
    J Clin Oncol. 2018 Jun 1:JCO2018793083. doi: 10.1200/JCO.2018.79.3083.
    PubMed     Text format    
    
    
17. HIDDEMANN W, Barbui AM, Canales MA, Cannell PK, et al
    Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety.
    J Clin Oncol. 2018 Jun 1:JCO2017768960. doi: 10.1200/JCO.2017.76.8960.
    PubMed     Text format     Abstract available
    
    
18. GOPAL AK, Schuster SJ, Fowler NH, Trotman J, et al
    Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study.
    J Clin Oncol. 2018 May 31:JCO2017768853. doi: 10.1200/JCO.2017.76.8853.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: